Ralf Koelbach

Associate Biostatistics Director

Ralf Koelbach is Associate Biostatistics Director at Cytel. Ralf brings more than 27 years of experience in clinical trials for CROs with a strong focus on MS in phases III-IV and other neurological diseases. His responsibilities include statistical input into the development of protocols, statistical analysis plans, statistical analyses, contribution to study reports, statistical lead activities and project management. Prior to joining Cytel in 2022, Ralf served as a Lead Biostatistician at Parexel International.

Ralf Koelbach

Related Articles

Analyzing Endpoints in Multiple Sclerosis Clinical Trials: Statistical Considerations
Blog
October 9, 2025
Analyzing Endpoints in Multiple Sclerosis Clinical Trials: Statistical Considerations
Read More